-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on FibroGen, Maintains $10 Price Target

Benzinga·05/13/2025 12:09:27
Listen to the news
HC Wainwright & Co. analyst Joseph Pantginis reiterates FibroGen (NASDAQ:FGEN) with a Buy and maintains $10 price target.